Menopause Supplement Global Market Report 2025

The menopause supplement market size has grown strongly in recent years. It will grow from $1.9 billion in 2024 to $2.05 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be linked to increasing awareness of menopause symptoms, growing preference for natural remedies, rising demand for non-hormonal alternatives, expansion of e-commerce platforms, and increasing availability of menopause-specific supplements.

The menopause supplement market size is expected to see strong growth in the next few years. It will grow to $2.77 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be driven by growing adoption of personalized health solutions, increasing focus on women's health and wellness, rising prevalence of menopause-related health conditions, expansion of telehealth services, and increasing investment in women's health startups. Major trends in the forecast period include advancements in personalized supplement formulations, integration of AI in menopause care, development of wearable technology for symptom tracking, innovations in plant-based supplement ingredients, and growth of menopause-focused wellness programs.

The increasing prevalence of menopausal symptoms is expected to drive growth in the menopause supplement market in the coming years. Menopausal symptoms refer to the physical and emotional changes women experience as their estrogen levels decline during the transition to menopause. This prevalence is rising as women live longer and spend more years in the postmenopausal phase, leading to prolonged exposure to both physical and hormonal changes. Menopause supplements are commonly used to help manage these symptoms by providing targeted nutrients and herbal compounds that can alleviate issues like hot flashes, mood swings, and sleep disturbances, while also supporting overall hormonal balance and well-being. However, usage varies depending on individual needs. For example, in December 2023, the National Library of Medicine, a U.S.-based government agency, reported that around 1.3 million women enter menopause each year, typically between the ages of 45 and 56, with 5% experiencing early menopause between 40 and 45, and 1% experiencing primary ovarian insufficiency before age 40. As a result, the rising prevalence of menopausal symptoms is a significant driver of the menopause supplement market’s growth.

Key companies in the menopause supplement market are focusing on advanced innovations, such as personalized supplements, to offer targeted symptom relief, improve efficacy, and cater to the unique hormonal and nutritional needs of individual women. Personalized supplements refer to customized nutritional formulations based on factors like health needs, symptoms, hormones, or lifestyle. For instance, in September 2025, Desert Harvest, a U.S.-based company known for developing natural health solutions, launched its first menopause supplement featuring human-identical lactoferrin. This product is notable for using lactoferrin that closely mimics the form naturally found in the human body. The supplement is designed to support women during peri- and post-menopause by addressing hormonal imbalances, fatigue, and immune health. By combining bioidentical lactoferrin with other natural ingredients, the company offers a non-hormonal, science-backed alternative for menopause relief. This launch also marks Desert Harvest’s entry into the rapidly expanding women’s health and menopause supplement market.

In June 2025, Hims & Hers Health, Inc., a U.S.-based health and wellness platform specializing in personalized healthcare, acquired ZAVA for an undisclosed amount. This acquisition allows Hims & Hers to extend its reach into Europe and leverage ZAVA’s established digital platform and medical expertise to deliver personalized, high-quality healthcare across multiple markets. ZAVA, a UK-based company, specializes in providing tests for menopause and treatments for related symptoms.

Major companies operating in the menopause supplement market are Nestlé Health Science, Procter & Gamble, Bayer AG, Church & Dwight Co. Inc., Herbalife Nutrition Ltd., Amway Corporation, The Nature's Bounty Co., GNC Holdings Inc., Pharmavite LLC, Blackmores Limited, NOW Foods, Thorne HealthTech, Metagenics Inc., Jarrow Formulas Inc., Nature's Way, Vitabiotics Ltd., Standard Process Inc., Swisse Wellness Pty Ltd., Bio-Botanica Inc., Life Extension

North America was the largest region in the menopause supplement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in menopause supplement report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the menopause supplement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The menopause supplement market research report is one of a series of new reports that provides menopause supplement market statistics, including the menopause supplement industry global market size, regional shares, competitors with the menopause supplement market share, detailed menopause supplement market segments, market trends, and opportunities, and any further data you may need to thrive in the menopause supplement industry. This menopause supplement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A menopause supplement is a dietary formulation designed to support women experiencing hormonal changes during the menopausal transition by helping alleviate common symptoms such as hot flashes, mood swings, and sleep disturbances. These supplements promote hormonal balance and overall well-being. They are used to naturally enhance quality of life during menopause without acting as pharmaceutical hormone replacement therapy.

The key product types of the menopause supplement market include hormonal supplements, non-hormonal supplements, nutritional supplements, and others. Hormonal supplements refer to formulations containing bioidentical or synthetic hormones such as estrogen, progesterone, or combinations thereof, designed to restore hormonal balance and alleviate symptoms associated with menopause, including hot flashes, mood swings, and night sweats. There are forms such as tablets, capsules, liquids, powders, gummies, and soft gels. The genders include women and men (with associated menopause-like conditions). The sales channels include store-based, modern trade, hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. The key end-users include hospitals, homecare, and clinics.

The menopause supplement market consists of sales of magnesium supplements, omega-3 fish oil capsules, herbal tea blends for menopause, collagen powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.